Thermo Fisher Scientific Inc (TMO)
Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell
$493.10
Buy
$500.00
$11.48 (+2.39%)
Prices updated at 31 Mar 2026, 13:13 EDT
| Prices minimum 15 mins delay
Prices in USD
Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Mr. Marc N. Casper
CEO
Mr. Marc N. Casper
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
125,000
Head office
168 Third Avenue
Waltham
United States
02451
Key personnel
Owner name | Salary |
|---|---|
Mr. Marc N. Casper Chairman of the Board and Chief Executive Officer | 1.74m |
Mr. Gianluca Pettiti Co-Chief Operating Officer and President | 0.96m |
Mr. Michael D. Shafer Executive Vice President | - |
Dr. C. Martin Harris,M.D. Independent Director | 0.14m |
Ms. Jennifer M. Johnson Independent Director | 0.13m |
Mr. Nelson J. Chai Independent Director | 0.15m |
Ms. Ruby R. Chandy Independent Director | 0.13m |
Mr. Scott M. Sperling Lead Independent Director | 0.17m |
Mr. James C. Mullen Independent Director | 0.13m |
Ms. Karen S. Lynch Director | - |
Professor Dr. Tyler E. Jacks, PhD Director | 0.15m |
Dr. Debora L. Spar Independent Director | 0.15m |
Mr. Dion J. Weisler Independent Director | 0.15m |
Mr. Lisa P. Britt Senior Vice President and Chief Human Resources Officer | - |
Ms. R. Alexandra Keith Independent Director | 0.13m |
Mr. Joseph R. Holmes Vice President and Chief Accounting Officer | - |
Mr. Thomas B. Shropshire, Jr Senior Vice President and General Counsel | - |
Mr. James R. Meyer Senior Vice President and Chief Financial Officer | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Vanguard Group Inc | 34,133,702 |
| J Stern & Co LLP | 31,509,332 |
| BlackRock Inc | 29,637,636 |
| State Street Corp | 16,384,131 |
| JPMorgan Chase & Co | 14,546,618 |
Director dealings
Date | Action |
|---|---|
| 31 Dec 2025 | - |
| 31 Dec 2025 | - |
| 31 Dec 2025 | - |
| 31 Dec 2025 | - |
| 31 Dec 2025 | - |
| 10 Dec 2025 | - |
| 04 Dec 2025 | - |
| 04 Dec 2025 | - |
| 04 Dec 2025 | - |
| 04 Dec 2025 | - |
| 04 Dec 2025 | - |
| 03 Dec 2025 | - |
| 03 Dec 2025 | - |
| 02 Dec 2025 | - |
| 02 Dec 2025 | - |
| 03 Dec 2025 | - |
| 03 Dec 2025 | - |
| 02 Dec 2025 | - |
| 02 Dec 2025 | - |
| 02 Dec 2025 | - |
Please note that past performance is not a reliable indicator of future returns.